Delivery Order SPE2DB20D1109-SPE2DB25FP41Z
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $37,550.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Eliquis 5 mg tablets. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,611.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $33,106.50 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.38 on July 18, 2025, for the supply of Eliquis 5 mg tablets (60-count). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for ultimate completion by July 21, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- This is a $17,726.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets over a period ending on March 6, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $50,127.96 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Eliquis 5 mg tablets. The contract has an ultimate completion date of June 11, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a $15,699.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a prescription anticoagulant medication. The order has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering...
- The U.S. Defense Logistics Agency (DLA) awarded a $132,002.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,427,049 units of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Eliquis 5 mg tablets. The total ceiling value of this contract is $22,619.00 with a period of performance through April 9, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) issued by DLA to AmerisourceBergen Drug Corp as a single award vehicle to supply...
- The Defense Logistics Agency awarded a delivery order valued at $16,372.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be completed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP41ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,665.21 to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, regularly fulfills DLA procurement requirements for a comprehensive range of pharmaceutical products serving military and veteran healthcare systems. This delivery order for Eliquis, an anticoagulant medication, represents a typical transaction under the broader IDC framework that enables the company to supply specialty medications, brand-name and generic drugs, and other medical commodities to support defense healthcare programs globally. The contract was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's capability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.7k | 7/18/25 |